Dupixent Lawyers of HLF A Division of The Hurwitz Law Firm PC · Lymphoma Attorneys

Delaware Dupixent Lawsuit Attorneys for CTCL Cancer Claims

DELAWARE DUPIXENT LAWYERS: Dover, Wilmington, Newark, and Middletown text on DE state flag adorned with a syringe and medical jar depicted near a coat of arms and 1787 date

Need a Delaware Dupixent lawsuit attorney?

Dover · Wilmington · Newark · Middletown

Call Now: (888) 510-9256

Hotline Open 24 Hours

Delaware Dupixent lawsuits claim anti-inflammatory drug-makers failed to protect patients from cancer. The medication has been blamed for many eczema and asthma patients developing cutaneous T-cell lymphoma. (See our DE Dupixent News)

As such, our Delaware Dupixent lawyers are filing CTCL cancer lawsuits for inflammation drug victims.


Delaware Dupixent Lawyers Advocate for T-Cell Cancer Victims

Our team of Delaware Dupixent attorneys has represented thousands of victims of dangerous pharmaceutical products. In doing so, we have recovered millions of dollars in settlement funds on their behalf.

However, we only pursue compensation from Dupixent manufacturers and affiliates, and do not file claims against our clients’ doctors or hospitals.


No Legal Fee Unless You Obtain a Settlement

While compensation may be available to qualified Dupixent claimants, victims are urged to act promptly. The #1 claim Delaware Dupixent victims can make for cancer compensation is one filed within the Statute of Limitations. Follow this link for our latest information on Dupixent multi-district litigation (MDL).

Our Delaware Dupixent lawyers are available to review claims now. We offer a free case evaluation to confirm use of Dupixent and diagnosis of a related cancer. Further, we never charge a legal fee unless a financial recovery is obtained for our client.

Get your Delaware Dupixent lawsuit review.



Delaware Dupixent Lawyers File Lymphoma Lawsuits Statewide

3rd Circuit Dupixent Claims in Delaware

Delaware is part of the Third Circuit of the federal court system, and Dupixent lawsuits can be filed at its local U.S. District Court. Eczema/Asthma medication appeals are heard by the 3rd Circuit Court of Appeals.

However, federal Dupixent lawsuits filed in Delaware may be transferred to a centralized jurisdiction pursuant to a lymphoma cancer Multi-District Litigation (MDL) Transfer Order. (Please follow this link for our additional information on 3rd Circuit Dupixent compensation.)


File Your 3rd Circuit Dupixent Settlement Claim Here text on depiction of Third Circuit court with syringe arm injection and high value cash backdrop.
File your Delaware Dupixent lawsuit in 3rd Circuit federal district court.

Delaware State Dupixent Claims

Delaware Dupixent lawyers can also file cancer lawsuits in the State’s county courts (DE Courts Website). The Delaware Rules of Civil Procedure sets forth the State’s procedural law for lymphoma claims.

The State of Delaware follows a modified comparative negligence rule. Accordingly, a Delaware Dupixent lawyer can recover damages for wrongful conduct by Regeneron Pharmaceuticals and Sanofi provided the plaintiff is less than 51% at fault. However, the inflammation patient’s recovery may be reduced by their own degree of fault (if any).

For FAQs about the ongoing T-cell lymphoma litigation, please see our Dupixent lawyers homepage.

Contact our Delaware Dupixent lawyers today.